Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Organisation › Details

Quantro Therapeutics GmbH

QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute of Molecular Pathology (“IMP”), both located in Vienna, Austria. Seed investors are Boehringer Ingelheim Venture Fund and Evotec. *

 

Period Start 2020-07-21 established (s-offc
  Predecessor IMBA – Institute of Molecular Biotechnology GmbH
Products Industry BIOTECH
  Industry 2 Transcriptional Fingerprinting technology
Persons Person Nachtigall, Dieter (Quantro Therapeutics 202007 CEO before Boehringer Ingelheim)
  Person 2 Ameres, Stefan (IMBA 2012– Group Lead + Quantro Therapeutics 202007 Co-Founder + Scientific Adivsor)
     
Region Region Wien (Vienna)
  Country Austria
  Street 7 Dr. Bohr-Gasse
Vienna BioCenter
  City 1030 Wien
  Tel +32-664-9158-111
    Address record changed: 2020-07-22
     
Basic data Employees n. a.
     
    * Document for �About Section�: Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna.
     
   
Record changed: 2020-08-04

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Quantro Therapeutics GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] No Content Marketing 650x80px




» top